Loading organizations...
§ Private Profile · Huangpu, Guangdong, China
Medical device company developing electrophysiology products for atrial fibrillation treatment, focused on 4D labelling systems.
Based in Guangzhou, China, EnChannel Medical is a venture-backed medical device manufacturer that develops next-generation electrophysiology products and comprehensive therapeutic solutions for treating atrial fibrillation. The company focuses on engineering a proprietary four-dimensional labeling system that utilizes magneto-electric positioning to provide real-time mapping of arrhythmia mechanisms during complex cardiac surgical procedures. Alongside its advanced diagnostic mapping technologies, the enterprise produces specialized pulsed field ablation tools designed to assist electrophysiologists and healthcare providers in performing safer surgical interventions. To support its ongoing clinical trials, internal research and development, and global commercialization efforts, the firm secured RMB 200 million ($28 million) in Series A financing backed by institutional investors including Longpan Investment, Lilly Asia Ventures, Lapam Capital, and Dragonball Capital. EnChannel Medical was officially founded in 2020 by senior electrophysiologists Jun Feng, Min Zhu, and Graydon Beatty.
EnChannel Medical has raised $83.9M across 1 funding round.
EnChannel Medical has raised $83.9M in total across 1 funding round.
EnChannel Medical has raised $83.9M across 1 funding round. Most recently, it raised $83.9M Series B in May 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2025 | $83.9M Series B | DragonBall Capital, Lilly Asia Ventures | Lapam Capital | Announced |
EnChannel Medical has raised $83.9M in total across 1 funding round.
EnChannel Medical's investors include DragonBall Capital, Lilly Asia Ventures, Lapam Capital.